251
panel
Food Is Medicine: Opportunities to Maximize, Expand, and Scale
In September, the White House published its National Strategy on Hunger, Nutrition, and Health,
resetting the course of US food policy.
+ Read More
panel
Time=Lives and Building the Clinical Trial Enterprise of the Future
This session will open with a Time=Lives Talk by Casey McPherson, Co-Founder and Chief Innovatio
n Officer, Everlum Bio and Founder and President, To Cure A Rose Foundation, foll
+ Read More
panel
FasterCures Advisors Meeting: A Conversation with Meena Seshamani (Invite only)
This annual meeting brings together the FasterCures Advisory Groups, including the Board, Busine
ss Council, and Changemakers nonprofit advisory council, to discuss timely topics across the biomedical research ecosystem. Dr.
+ Read More
panel
Conversation with Placeholder
panel
Speakers/Moderators Declined/Cancelled
panel
Open Private Session (Invite only)
video
Health Reform II: Where Do We Go From Here?
video
Rethinking Financing for Global Health
article
Food and Drug Administration (FDA) - Patient Perspectives on Gene Therapy Products
Submitted electronically
Division of Dockets Management (HFA-305)
Food and Drug Administration
Dock
et No: FDA-2022-N-2394
5630 Fishers Lane
Room 1061
Rockville, MD 20852
+ Read More
article
OSTP RFI on Clinical Research Infrastructure and Emergency Clinical Trials
Submitted electronically
Dr. Arati Prabhakar
Director
Office of Science and Technology Policy The W
hite House
Washington, DC 20502
+ Read More
article
Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package
The Milken Institute applauds Congress on the passage of the FY2023 Omnibus Appropriations bill.